These discrepancies highlight a critical gap in our understanding, suggesting that the influence of ADIPOQ may be context-dependent, varying with ethnicity, the specific clinical phenotype being examined (e.g., PCOS risk vs. obesity within PCOS), and potential interactions with other genetic and environmental factors. Here, ADIPOQ is linked to polycystic ovary syndrome.